Arrowstreet Capital
ADPT icon

Arrowstreet Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Arrowstreet Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.7M Sell
1,995,202
-426,887
-18% -$6.8M 0.02% 660
2025
Q4 		$39.3M Sell
2,422,089
-19,313
-0.8% -$315K 0.02% 541
2025
Q3 		$36.5M Buy
2,441,402
+2,062,282
+544% +$25.1M 0.02% 550
2025
Q2 		$4.42M Buy
379,120
+333,379
+729% +$3.03M ﹤0.01% 1218
2025
Q1 		$340K Buy
+45,741
New +$352K ﹤0.01% 1664
2021
Q1 		– Sell
-160,810
Closed -$9.51M – 2205
2020
Q4 		$9.51M Buy
+160,810
New +$8.29M 0.01% 902
2020
Q2 		– Sell
-74,715
Closed -$2.08M – 2269
2020
Q1 		$2.08M Buy
+74,715
New +$2.08M 0.01% 1051

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return